Tien Liang Biotech Co Ltd banner
T

Tien Liang Biotech Co Ltd
TPEX:4127

Watchlist Manager
Tien Liang Biotech Co Ltd
TPEX:4127
Watchlist
Price: 92.3 TWD 2.56% Market Closed
Market Cap: NT$4.2B

Intrinsic Value

The intrinsic value for Tien Liang Biotech Co Ltd (4127) under the Base Case is 34.41 TWD. Compared with the current market price of 92.3 TWD, the stock appears Overvalued by 63% .

Intrinsic value calculated using Multiples
NT$34.41
Other reference points

Do our valuations actually work? See backtest results .

Intrinsic Value
NT$34.41
Overvaluation 63%
Intrinsic Value
Price NT$92.3
T
Monitor Tien Liang Biotech Co Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value NT$27.53
Get notified when the price drops into your buy zone
Current Price NT$92.3
Intrinsic Value NT$34.41
Margin of Safety 20% NT$27.53
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about Tien Liang Biotech Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Tien Liang Biotech Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Tien Liang Biotech Co Ltd.

Explain Valuation
Alternatives to Tien Liang Biotech Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Tien Liang Biotech Co Ltd stock?

The intrinsic value for Tien Liang Biotech Co Ltd (4127) under the Base Case is 34.41 TWD.

Is Tien Liang Biotech Co Ltd stock undervalued or overvalued?

Compared with the current market price of 92.3 TWD, the stock appears Overvalued by 63% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett